Results 281 to 290 of about 19,007,438 (352)

Accuracy of glomerular filtration rate estimation based on creatinine and cystatin C for monitoring moderate chronic kidney disease in adults: prospective, longitudinal cohort study.

BMJ
Scandrett K, Sitch AJ, Barratt J, Brettell EA, Cockwell P, Dalton RN, Deeks JJ, Eaglestone G, Kalra PA, Khunti K, Loud FC, Ottridge R, Pellatt-Higgins T, Potter A, Rowe C, Sharpe CC, Shinkins B, Smith A, Stevens PE, Sutton AJ, Taal MW, Lamb EJ.   +21 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial

Lancet, The, 2021
Bon-Kwon Koo, Jeehoon Kang, Kyung Woo Park   +2 more
exaly   +2 more sources

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

Lancet Oncology, The, 2015
Antoni Ribas, Igor Puzanov, Reinhard Dummer   +2 more
exaly   +2 more sources

The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis

Journal of the American Academy of Dermatology, 2020
BACKGROUND An Investigator Global Assessment (IGA) is recommended by health agencies for drug registration in atopic dermatitis (AD). Current IGA scales lack standardization.
Robert Bissonnette, Lawrence Eichenfield, Brett A King   +2 more
exaly   +2 more sources

Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial

Lancet Oncology, The, 2017
Kevin J Harrington, Robert L Ferris, Lisa F Licitra   +2 more
exaly   +2 more sources

TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial.

The Lancet Oncology, 2020
BACKGROUND TAS-102 (trifluridine-tipiracil) has shown a significant overall survival benefit compared with placebo in patients with chemorefractory metastatic colorectal cancer. Inspired by the encouraging results of a small phase 1-2 study, C-TASK FORCE,
P. Pfeiffer, M. Yilmaz, S. Möller, D. Žitnjak, M. Krogh, L. Petersen, L. Poulsen, S. Winther, K. Thomsen, C. Qvortrup   +9 more
semanticscholar   +1 more source

Cyber Crime Investigator's Field Guide

, 2022
From the Publisher: Long gone are the days when a computer took up an entire room. Now we have computers at home, laptops that travel just about anywhere, and data networks that allow us to transmit information from virtually any location in a timely ...
B. Middleton, B. Lipták
semanticscholar   +1 more source

Investigator Triangulation

Journal of Mixed Methods Research, 2016
Mandy M Archibald
exaly   +2 more sources

Investigating Investigators: Examining Witnesses' Influence on Investigators.

Law and Human Behavior, 2006
This research examined the influence of eyewitness identification decisions on participants in the role of police investigators. Undergraduate "investigators" interviewed confederate "witnesses" and then searched a computer database of potential suspects.
Leora C. Dahl, D. Stephen Lindsay, C. A. Elizabeth Brimacombe   +2 more
openaire   +2 more sources